USAN Watch: September 2013

The USANs for September, 2013 have recently been published. We actually missed September, due to switch over in service for the INNs, but now they're here.

USAN	Research Code	InChIKey (Parent)	Drug Class	Therapeutic class	Target
aducanumab	BIIB-037	n/a	monoclonal antibody	therapeutic	beta amyloid
aptorsen-sodium	OGX-427	n/a	oligonucleotide	therapeutic	HSP27
asfotase-alfa	ALXN-1215, ENB-0040	n/a	enzyme	therapeutic	n/a
batefenterol, batefenterol-succinate	GSK-961081A	URWYQGVSPQJGGB-DHUJRADRSA-N	synthetic small molecule	therapeutic	Muscarinic receptors, B2 receptor
bococizumab	RN-316, PF-04950615	n/a	monoclonal antibody	therapeutic	PC9
dactolisib, dactolisib-tosylate	NVP-BEZ235-NX	JOGKUKXHTYWRGZ-UHFFFAOYSA-N	synthetic small molecule	therapeutic	MTOR, PI3K
deldeprevir, deldeprevir-sodium	ACH-0142684, ACH-2684	UDMJANYPQWEDFT-ZAWFUYGJSA-N	synthetic small molecule	therapeutic	HCV NS3 PR
etiguanfacine	SSP-1871	NWKJFUNUXVXYGE-UHFFFAOYSA-N	synthetic small molecule	therapeutic
faldaprevir, faldaprevir-sodium	BI-201335		synthetic small molecule	therapeutic	HCV NS3 PR
fedratinib	SAR-302503; TG-101348	JOOXLOJCABQBSG-UHFFFAOYSA-N	synthetic small molecule	therapeutic	FLT3, JAK2
grazoprevir	n/a	n/a	synthetic small molecule	therapeutic
irinotecan-sucrosofate	MM-398, PEP-02	n/a	natural product derived small molecule	therapeutic	topo 1
luspatercept	ACE-536	n/a	protein	therapeutic	TGF-B family
mavoglurant	AFQ-056	ZFPZEYHRWGMJCV-ZHALLVOQSA-N	synthetic small molecule	therapeutic	mGluR5
otlertuzumab	TRU-016	n/a	monoclonal antibody	therapeutic	CD37
ralpancizumab	RN317, PF-05335810	n/a	monoclonal antibody	therapeutic	PC9
romyelocel-l	CLT-008	n/a	cellular therapy	therapeutic	n/a
roxadustat	FG-4592; ASP-1517	YOZBGTLTNGAVFU-UHFFFAOYSA-N	synthetic small molecule	therapeutic	prolyl hydoxylase
simtuzumab	AB-0024; GS-6624	n/a	monoclonal antibody	therapeutic	LOXL2
sucroferric-oxyhydroxide	PA-21	n/a	inorganic	sequestering agent	n/a
tecemotide	BLP-25	n/a	peptide vaccine	peptide vaccine	n/a

Usan Watch: October 2013

The USANs for October 2013 have recently been published.



We have modified the sourcing of this data - using the new ChEMBL API to automatically parse the documents, extract and validate the mol files for the compounds. So in future, these reports should be more timely, complete and fun!

USAN	Research Code	InChIKey (Parent)	Drug Class	Therapeutic class	Target
alectinib	AF-802; CH-5424802	KDGFLJKFZUIJMX-UHFFFAOYSA-N	synthetic small molecule	therapeutic	ALK
apitolisib	GDC-0980.1, G-038390, G-038390.1, RG-7422	YOVVNQKCSKSHKT-HNNXBMFYSA-N	synthetic small molecule	therapeutic	MTOR,PI3K
cimaglermin-alfa	GGF2, rhGGF2	n/a	protein	therapeutic	ErbB
decernotinib	VX-509, VRT-831509	ASUGUQWIHMTFJL-QGZVFWFLSA-N	synthetic small molecule	therapeutic	JAK3
elobixibat	A-3309; AZD-7806	XFLQIRAKKLNXRQ-UUWRZZSWSA-N	n/a	therapeutic	SLC10A2
ipatasertib	GDC-0068; RG-7440	GRZXWCHAXNAUHY-NSISKUIASA-N	synthetic small molecule	therapeutic	AKT
lixisenatide	AVE-0010	n/a	peptide	therapeutic	GLP1R
ulocuplumab	MDX-1338, BMS-936564	n/a	monoclonal antibody	therapeutic	CXCR4